Becton Dickinson, US0718131099

Becton Dickinson stock holds near its 52 week high

Published on 09/01/2026 at 16:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Becton Dickinson stock traded at USD 188.13 on September 1, 2026, with a market cap of USD 51.84 billion and a 1-year high of USD 193.07. The company also reported Q3 fiscal 2026 revenue of USD 5.0 billion and adjusted EPS of USD 3.23.

Isometrische 3D-Illustration der Medizintechnik-Lieferkette von Rohstoff bis Krankenhaus
Becton Dickinson globale Lieferkette isometrisch als 3D Diagramm visualisiert, Wertpapier US0718131099 NYSE, Illustration mit AI erstellt.

Becton Dickinson stock (ISIN US0718131099) traded at USD 188.13 on September 1, 2026, with a market cap of USD 51.84 billion and a 1-year range of USD 127.59 to USD 193.07. The latest quarterly update showed Q3 fiscal 2026 revenue of USD 5.0 billion and adjusted EPS of USD 3.23, according to a market report published on September 1, 2026.

Q3 numbers stay central

The same Q3 fiscal 2026 update puts reported revenue growth at 5.4 percent and foreign exchange neutral growth at 4.4 percent. GAAP diluted EPS from continuing operations was USD 1.64, while adjusted diluted EPS reached USD 3.23, a gap that shows how much non-recurring items still shape the headline profit line.

For investors, the comparison matters: adjusted EPS rose from the prior quarter basis cited in the report and revenue crossed the USD 5 billion mark in a period that the company described as its third quarter of fiscal 2026.

Dividend and valuation

The stock also carried a quarterly dividend of USD 1.05, with the record date set for September 9, 2026 and payment scheduled for September 30, 2026. At USD 188.13, the shares traded 2.5 percent below the 1-year high of USD 193.07 and 47.3 percent above the 1-year low of USD 127.59.

That combination leaves the valuation debate tied to earnings quality rather than the chart alone. The market price, the USD 51.84 billion market cap and the USD 3.23 adjusted EPS reading all point to a stock where the next move depends on how steadily earnings translate into cash and guidance.

Go deeper

More on Becton Dickinson stock

The company reported its latest quarterly revenue, EPS and dividend timeline in a fresh market update dated September 1, 2026.

Medical tools remain the core

Becton Dickinson's business still centers on medical technology, with consumables and devices providing the steady base behind the quarterly numbers. The latest earnings set places that base in focus because revenue of USD 5.0 billion and adjusted EPS of USD 3.23 leave little room for a purely narrative read.

Price and market setup

As of September 1, 2026, Becton Dickinson stock traded at USD 188.13 on the U.S. market. The 1-year high stood at USD 193.07 and the 1-year low at USD 127.59, keeping the current quote close to the upper end of the range.

Becton Dickinson facts

  • Company: Becton, Dickinson and Company
  • ISIN: US0718131099
  • Ticker: BDX
  • Trading venue: NYSE
  • Price (as of September 1, 2026): USD 188.13
  • Market capitalization: USD 51.84 billion (as of September 1, 2026)
  • Sector / Industry: Health Care / Medical Instruments & Supplies
  • Index membership: S&P 500

Disclaimer...

en | US0718131099 | BECTON DICKINSON | boerse | 70037633 | bgmi